Oncotarget Can the Creatine Shuttle be Targeted to Fight Colorectal Cancer? In a new study, researchers investigated the creatine shuttle pathway as a potential therapeutic target... read more May 25, 2023
Oncotarget Reaching the Brain Through the Groin: A Novel Approach to Brain Cancer In a new editorial, researchers discuss opening the blood-brain barrier and a promising new strategy... read more May 11, 2023
Oncotarget Defining the Complexity of EGFR Endocytosis in Cancer The Trending With Impact series highlights Oncotarget publications attracting higher visibility among readers around the... read more April 27, 2023
Oncotarget The Evolution of Metastatic Cancer: Mechanisms and Drivers The Trending With Impact series highlights Oncotarget publications attracting higher visibility among readers around the... read more April 14, 2023
Oncotarget Targeting Pre-Leukemic Cells: New Hope for Preventing Childhood B-ALL Researchers from Universidad Autónoma de Madrid published a new editorial in Oncotarget detailing a... read more March 31, 2023
Oncotarget Unconventional Protein Secretion (UPS) in Cancer Researchers from The Jikei University School of Medicine published a recent editorial perspective in Oncotarget,... read more March 16, 2023
Oncotarget The Role of Kras and Canonical Wnt Pathways in Biliary Tract Cancers In a recent Oncotarget editorial, researchers discuss Kras and the canonical Wnt pathway in biliary... read more March 1, 2023
Oncotarget Oncotarget’s Top 10 Papers in 2022 (Crossref Data) Crossref is a non-profit organization that logs and updates citations for scientific publications. Each month,... read more February 22, 2023
Oncotarget Controlling Glycolytic Flux: Therapy Challenges and Solutions In a new editorial paper, researchers from the University of Oxford explore challenges and potential... read more February 16, 2023
Oncotarget The Importance of CD56 in the Fight Against Multiple Myeloma In a new Oncotarget editorial, researchers discussed their study on CD56 in multiple myeloma.The... read more February 2, 2023